Picture Berlin Partner Top News Tacalyx Extends Seed Round to €14m 650x100px
Document › Details

CureVac AG. (2/19/19). "Press Release: CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference". Tübingen & Boston, MA.

Region Region New York, NY
  Country United States (USA)
Organisations Organisation CureVac AG
  Today CureVac SE
  Group CureVac (Group)
  Organisation 2 SVB Leerink LLC
  Today Leerink Partners (Group)
  Group Leerink Partners (Group)
Products Product SVB Leerink Annual Global Healthcare Conference 2019 New York
  Product 2 mRNA-based drug
Index term Index term CureVac–SVB: investor conference, 201902 supply service CureVac presents at SVB Leerink Global Healthcare Conference in NYC
Person Person Menichella, Daniel L. (Dan) (Kaleido Biosciences 202010– CEO before CureVac + Bamboo Therapeutics + AGTC + Zyngenia)

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 8th Annual Leerink Partners Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 1:50 p.m. ET.

A live broadcast of the presentation will be available at An archived replay of the presentation will be available on the company’s website for approximately 3 months following the presentation.

Record changed: 2023-06-05


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for CureVac (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top